Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in APLS — Apellis Pharmaceuticals, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in APLS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
340,086
-36.3% QoQ
Ownership
0.266%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in APLS Over Time

Shares Held

Position Value (USD)

Derivatives in APLS

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
280,600
PutValue
$0
PutShares
163,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,650,012,247 across 349 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in APLS

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 280,600
2026-03-31 340,086
2026-03-31 163,600
2025-12-31 533,909
2025-12-31 110,800
2025-12-31 657,200
2025-09-30 313,884
2025-09-30 469,000
2025-09-30 75,700
2025-06-30 165,900
2025-06-30 516,800
2025-06-30 328,726
2025-03-31 323,500
2025-03-31 169,600
2025-03-31 29,505
2024-12-31 859,200
2024-12-31 26,217
2024-12-31 152,600
2024-09-30 212,800
2024-09-30 787,500
2024-09-30 171,792
2024-06-30 274,900
2024-06-30 1,028,800
2024-06-30 478,963
2024-03-31 321,800
2024-03-31 244,261
2024-03-31 331,100
2023-12-31 382,832
2023-12-31 945,700
2023-12-31 387,200
2023-09-30 372,785
2023-09-30 395,700
2023-09-30 1,019,700
2023-06-30 315,910
2023-06-30 228,800
2023-06-30 155,000
2023-03-31 81,796
2023-03-31 336,400
2023-03-31 358,200
2022-12-31 219,000
2022-12-31 31,732
2022-12-31 187,800
2022-09-30 57,860
2022-09-30 152,500
2022-09-30 163,300
2022-06-30 71,500
2022-06-30 53,780
2022-06-30 31,000
2022-03-31 179,500
2022-03-31 136,900